FoxFeed Blog

Latest Blog Posts Tagged "Academia/Nonprofit"

Ask the MD: Constipation and Parkinson's

December 11, 2017

Dr. Dolhun discusses constipation, a common non-motor symptom in Parkinson's, and ways to treat it.

What We Need to Know to Advance Most Promising Parkinson's Therapies

October 24, 2017

In a recent review paper, top Parkinson's experts outline unanswered questions hindering development of treatments against key protein alpha-synuclein.

Update on Alpha-synuclein Therapies in Clinical Trials

July 10, 2017

Five projects targeting alpha-synuclein are in clinical trials with more preparing for testing.

MJFF Scientist Highlights Alpha-synuclein Research Progress in Nature Reviews Drug Discovery

June 29, 2017

MJFF scientist speaks to "Nature Reviews Drug Discovery" about alpha-synuclein research progress in Parkinson's disease.

New Findings Add to Evidence of Immune System Role in Parkinson's Disease

June 22, 2017

MJFF-funded researchers published on a connection between the key Parkinson's protein alpha-synuclein and the immune system. This finding may point to a new way to stop or slow disease.

Tracing the Origins of Parkinson's to the Gut

May 02, 2017

A new study builds on the theory that PD could start in the gut, rather than the brain.

MJFF Study Making Strides Toward Parkinson's Biomarker

April 13, 2017

Researchers haven't yet determined the optimal location or method to sample alpha-synuclein. Learn how MJFF's Systemic Synuclein Sampling Study is hoping to change this.

New Information on the Parkinson's-Gut Connection

March 20, 2017

A recently published study has revealed differences in gut bacteria in those with Parkinson's disease based on their medications and geographic locations, adding to our growing knowledge.

First Trial Begins Testing Drug in People with GBA Mutation

February 14, 2017

This study is a major step for PD research as it is the first drug trial where one's genetic information determines eligibility and is testing a potential therapy to slow or stop disease progression.